These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20348168)

  • 1. Aspirin in primary prevention. Evidence is lacking.
    Burrill PD
    BMJ; 2010 Mar; 340():c1613. PubMed ID: 20348168
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
    Collins R; Peto R; Baigent C; Sleight P
    N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin and women--age matters. Aspirin can help healthy women over age 56 prevent both strokes and heart attacks. For younger women, the hazards of aspirin outweigh the benefits.
    Harv Heart Lett; 2005 May; 15(9):1-2. PubMed ID: 15898147
    [No Abstract]   [Full Text] [Related]  

  • 4. Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)?
    Olson J; Huntington J
    J Fam Pract; 2001 Jul; 50(7):623. PubMed ID: 11485713
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin and primary prevention. BHS reaffirms its guidance.
    Sever PS;
    BMJ; 2010 Mar; 340():c1183. PubMed ID: 20197334
    [No Abstract]   [Full Text] [Related]  

  • 7. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin prevents strokes in middle-aged and older women, heart attacks in older women.
    Mayo Clin Womens Healthsource; 2005 Oct; 9(10):3. PubMed ID: 16224352
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin to prevent heart attack and stroke: what's the right dose?
    Dalen JE
    Am J Med; 2006 Mar; 119(3):198-202. PubMed ID: 16490462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ; Jonas MA; Hennekens CH
    Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015
    [No Abstract]   [Full Text] [Related]  

  • 11. [Primary prevention of coronary thrombosis by antithrombotic agents].
    Milon H; Lantelme P; Khettab F; Mestre-Fernandes C; Lasserre-Remy S
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1243-50. PubMed ID: 11794965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.
    Yusuf S; Sleight P; Held P; McMahon S
    Circulation; 1990 Sep; 82(3 Suppl):II117-34. PubMed ID: 1975522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombotic treatment of atrial fibrillation].
    Connelly SJ; Turpie AG
    Can J Cardiol; 1996 Feb; 12 Suppl A():14A-18A. PubMed ID: 8673946
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized controlled trial of aspirin in the prevention of early mortality in myocardial infarction.
    Elwood PC; Williams WO
    J R Coll Gen Pract; 1979 Jul; 29(204):413-6. PubMed ID: 392079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Don't use aspirin for primary prevention of cardiovascular disease.
    Barnett H; Burrill P; Iheanacho I
    BMJ; 2010 Apr; 340():c1805. PubMed ID: 20410163
    [No Abstract]   [Full Text] [Related]  

  • 16. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of aspirin to prevent myocardial infarction and adverse outcome during follow-up - a large series of all-comers.
    Mikkelsson J; Eskola M; Nikus K; Karhunen PJ; Niemela K
    Ann Med; 2008; 40(4):296-302. PubMed ID: 18428022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin for the primary prevention of myocardial infarction.
    Relman AS
    N Engl J Med; 1988 Jan; 318(4):245-6. PubMed ID: 3275897
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Throw away the aspirin and take nonsteroidal anti-inflammatory drugs for the primary prevention of myocardial infarction.
    Eliasziw M; Hill MD
    Circulation; 2004 Feb; 109(7):e65-6; author reply e65-6. PubMed ID: 14981016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.